200 related articles for article (PubMed ID: 22927676)
1. A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.
Mathews LA; Keller JM; Goodwin BL; Guha R; Shinn P; Mull R; Thomas CJ; de Kluyver RL; Sayers TJ; Ferrer M
J Biomol Screen; 2012 Oct; 17(9):1231-42. PubMed ID: 22927676
[TBL] [Abstract][Full Text] [Related]
2. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.
Nishi M; Akutsu H; Kudoh A; Kimura H; Yamamoto N; Umezawa A; Lee SW; Ryo A
Oncotarget; 2014 Sep; 5(18):8665-80. PubMed ID: 25228591
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput screen identifies inhibitors of lung cancer stem cells.
She X; Gao Y; Zhao Y; Yin Y; Dong Z
Biomed Pharmacother; 2021 Aug; 140():111748. PubMed ID: 34044271
[TBL] [Abstract][Full Text] [Related]
4. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
[TBL] [Abstract][Full Text] [Related]
5. Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer.
Shaheen S; Ahmed M; Lorenzi F; Nateri AS
Stem Cell Rev Rep; 2016 Aug; 12(4):492-9. PubMed ID: 27207017
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic high-throughput screening elucidates target pathway in breast cancer stem cell-like cells.
Carmody LC; Germain AR; VerPlank L; Nag PP; Muñoz B; Perez JR; Palmer MA
J Biomol Screen; 2012 Oct; 17(9):1204-10. PubMed ID: 22941295
[TBL] [Abstract][Full Text] [Related]
7. High throughput-screening of native herbal compounds identifies taccaoside A as a cytotoxic compound that mediates RAS signaling in cancer stem cells.
Yang D; Dai Z; Zhu P; Wang G; Sun B; Li S; Hao J; Wang Y; Liu Y; Yu S; Lai R; Luo XD; Zhao X
Phytomedicine; 2023 Jan; 108():154492. PubMed ID: 36257220
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
Hii LW; Chung FF; Soo JS; Tan BS; Mai CW; Leong CO
Breast Cancer Res Treat; 2020 Feb; 179(3):615-629. PubMed ID: 31784862
[TBL] [Abstract][Full Text] [Related]
9. Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70.
Hyun SY; Le HT; Min HY; Pei H; Lim Y; Song I; Nguyen YTK; Hong S; Han BW; Lee HY
Theranostics; 2021; 11(6):2932-2952. PubMed ID: 33456581
[No Abstract] [Full Text] [Related]
10. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate.
Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M
Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093
[TBL] [Abstract][Full Text] [Related]
11. A Cytotoxic Three-Dimensional-Spheroid, High-Throughput Assay Using Patient-Derived Glioma Stem Cells.
Quereda V; Hou S; Madoux F; Scampavia L; Spicer TP; Duckett D
SLAS Discov; 2018 Sep; 23(8):842-849. PubMed ID: 29750582
[TBL] [Abstract][Full Text] [Related]
12. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
[TBL] [Abstract][Full Text] [Related]
13. Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening.
Goričan L; Gole B; Potočnik U
Cells; 2020 Jul; 9(7):. PubMed ID: 32708734
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells as a target population for drug discovery.
Bouvard C; Barefield C; Zhu S
Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells as the relevant biomass for drug discovery.
Winquist RJ; Furey BF; Boucher DM
Curr Opin Pharmacol; 2010 Aug; 10(4):385-90. PubMed ID: 20630801
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
[TBL] [Abstract][Full Text] [Related]
17. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
[TBL] [Abstract][Full Text] [Related]
18. NANOG: a promising target for digestive malignant tumors.
Sun AX; Liu CJ; Sun ZQ; Wei Z
World J Gastroenterol; 2014 Sep; 20(36):13071-8. PubMed ID: 25278701
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations.
Lopez-Ayllon BD; Moncho-Amor V; Abarrategi A; Ibañez de Cáceres I; Castro-Carpeño J; Belda-Iniesta C; Perona R; Sastre L
Cancer Med; 2014 Oct; 3(5):1099-111. PubMed ID: 24961511
[TBL] [Abstract][Full Text] [Related]
20. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
